Industry comparison
Biotechnology
CodeNameLastChange(%)ascendingP/EYield (%)P/E Range
LYELLyell Immunopharma0.6095-2.73%---- 
GUTSFractyl Health1.99-2.69%---- 
TENXTenax Therapeutics6.21-2.66%---- 
AUTLAutolus Therapeutics plc2.2-2.65%---- 
IKNAIkena Oncology1.48-2.63%---- 
OCGNOcugen0.712-2.61%---- 
ALVRAlloVir Inc9.7-2.51%---- 
BEAMBeam Therapeutics25.26-2.51%---- 
CYTKCytokinetics48.7-2.48%---- 
IMNNImunon0.9136-2.48%---- 
PHGEBiomX Inc0.7801-2.48%---- 
IVAInventiva SA2.2238-2.46%---- 
GLYCGlycoMimetics0.2522-2.44%---- 
TECHBio-Techne Corp74.6-2.42%80.470.43PE
EYENEyenovia0.057-2.40%---- 
ANTXAN2 Therapeutics1.23-2.38%---- 
EYPTEyePoint Pharmaceuticals7.83-2.37%---- 
ABUSArbutus Biopharma Corp3.35-2.33%---- 
TELOTelomir Pharmaceuticals4.64-2.32%---- 
ALECAlector1.7-2.30%---- 
Smiley faceQuotes are at least 15-min delayed:2025/01/28 18:04 EDT
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.